| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer
|
Vaklavas, Christos
|
|
|
198 |
2 |
p. 217-229
|
artikel
|
| 2 |
Chemotherapy refusal and subsequent survival in healthy older women with high genomic risk estrogen receptor-positive breast cancer
|
White, McKenzie J.
|
|
|
198 |
2 |
p. 309-319
|
artikel
|
| 3 |
Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018
|
de Maar, Josanne S.
|
|
|
198 |
2 |
p. 253-264
|
artikel
|
| 4 |
Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
|
Kim, Sung Eun
|
|
|
198 |
2 |
p. 231-237
|
artikel
|
| 5 |
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment
|
Hogan, Molly P.
|
|
|
198 |
2 |
p. 349-359
|
artikel
|
| 6 |
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status
|
Rosenberg, Shai
|
|
|
198 |
2 |
p. 197-205
|
artikel
|
| 7 |
Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
|
Sund, Maria
|
|
|
198 |
2 |
p. 361-368
|
artikel
|
| 8 |
False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features
|
Alikhassi, Afsaneh
|
|
|
198 |
2 |
p. 321-334
|
artikel
|
| 9 |
High maximum standardized uptake value might be associated more with T2b (≥ 4 cm) than T2a (< 4 cm) in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer
|
Altundag, Kadri
|
|
|
198 |
2 |
p. 403
|
artikel
|
| 10 |
Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute: a cohort study of 251 cases
|
van Loevezijn, Ariane A.
|
|
|
198 |
2 |
p. 295-307
|
artikel
|
| 11 |
International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients
|
de Ligt, K. M.
|
|
|
198 |
2 |
p. 265-281
|
artikel
|
| 12 |
Mitigating fear of cancer recurrence
|
Sorscher, Steven
|
|
|
198 |
2 |
p. 401
|
artikel
|
| 13 |
Molecular characteristics of Asian male BRCA-related cancers
|
Kwong, Ava
|
|
|
198 |
2 |
p. 391-400
|
artikel
|
| 14 |
Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio
|
Eom, Kirsten Y.
|
|
|
198 |
2 |
p. 369-381
|
artikel
|
| 15 |
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study
|
Magbanua, Mark Jesus M.
|
|
|
198 |
2 |
p. 383-390
|
artikel
|
| 16 |
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry
|
Ibragimova, Khava I. E.
|
|
|
198 |
2 |
p. 239-251
|
artikel
|
| 17 |
Pregnancy-associated breast cancer: does timing of presentation affect outcome?
|
Crown, Angelena
|
|
|
198 |
2 |
p. 283-294
|
artikel
|
| 18 |
Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer who underwent adjuvant chemotherapy
|
Han, Sangwon
|
|
|
198 |
2 |
p. 207-215
|
artikel
|
| 19 |
Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
|
Engelking, Marta
|
|
|
198 |
2 |
p. 187-195
|
artikel
|
| 20 |
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk
|
Allman, Richard
|
|
|
198 |
2 |
p. 335-347
|
artikel
|
Tijdschrift beschrijving